Opinion
Video
Author(s):
In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.
0:50 Need for using older diabetes medications
3:30 Quick-release bromocriptine: benefits in T2D and cardiovascular risk
6:15 Efficacy of quick-release bromocriptine
8:10 Quick-release bromocriptine as monotherapy and as an add-on
9:00 Mechanism of quick-release bromocriptine
11:41 Titrating quick-release bromocriptine
15:50 Benefits of pioglitazone
22:30 Positioning older T2D therapies in the current treatment regimen